Proscia has made its Concentriq Dx digital pathology software available for use in reviewing and reporting of digital pathology slides in the United States. In Europe, Concentriq Dx is CE-marked for use in primary diagnosis. In the United States, the software will support the need for remote pathology brought about by the COVID-19 pandemic. The company’s announcement comes as FDA has issued new guidance aimed at expanding the availability of remote digital pathology devices.